Eckert & Ziegler Strahlen- Und Medizinte - EUZ- Profile

Eckert & Ziegler Strahlen- und Medizinte(EZAG). The Group's principal activities are to develop, test, produce and market radioactive components. The Group's activities are carried through two divisions: The Nuclear Imaging and Industry segment and the Therapy segment. The Nuclear Imaging and Industry segment manufactures and sells standards as well as radiation source materials for industrial and medical applications. The Therapy segment develops and markets radioactive sources in the cardiological and oncological fields. The Group's products include medical equipments, especially for cancer therapy as well as medical nuclear imaging and industrial metrology. The Group operates in North America, Europe, Asia-Pacific and others. The Group acquired SORAD s.r.o., Prague in August 2005. Nuclear imaging and industry accounted for 60% of 2005 revenues; Therapy, 40% and Other, nominal